Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 19;19(1):20220929.
doi: 10.1515/biol-2022-0929. eCollection 2024.

Knockdown of USP7 alleviates atherosclerosis in ApoE-deficient mice by regulating EZH2 expression

Affiliations

Knockdown of USP7 alleviates atherosclerosis in ApoE-deficient mice by regulating EZH2 expression

Yu Zhang et al. Open Life Sci. .

Abstract

Atherosclerosis (AS) is a chronic vascular disease associated with lipid accumulation. Understanding the molecular mechanisms of AS is essential. Ubiquitin-specific protease 7 (USP7) is a deubiquitination enzyme involved in various cellular processes, including lipid metabolism. In this study, we aimed to elucidate the role of USP7 in AS progression and its underlying mechanism using ApoE-deficient mice. We found that USP7 ablation improved the morphological characteristics of AS in these mice. USP7 knockdown reduced inflammation, evidenced by decreases in inflammatory markers IL-6, TNF-α, and IL-1β by 35, 40, and 38%, respectively (p < 0.01). Additionally, USP7 depletion reduced oxidative stress, indicated by a 30% reduction in malondialdehyde levels and increases in superoxide dismutase and glutathione peroxidase levels by 25 and 28%, respectively (p < 0.01). Moreover, USP7 knockdown blocked lipid accumulation in aortic tissue cells. Mechanistically, USP7 knockdown inhibited enhancer of Zeste Homolog 2 (EZH2) expression, thereby suppressing AS progression. In conclusion, USP7 depletion alleviated AS progression in ApoE-deficient mice by targeting EZH2 expression. USP7 may serve as a therapeutic target for AS.

Keywords: EZH2; atherosclerosis; inflammation; oxidative stress; ubiquitin-specific protease 7.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Authors state no conflict of interest.

Figures

Figure 1
Figure 1
Ablation of USP7 improved the AS morphological characteristics in AS mice. (a) Immunoblot assays showed the expression of USP7 in aortic tissues of normal mice and AS (ApoE-deficient) mice, as well as AS mice infected with sh-NC or sh-USP7 adenovirus plasmids for 24 h. (b) H&E staining showed the aortic morphology in normal mice and AS (ApoE-deficient) mice, as well as AS mice infected with sh-NC or sh-USP7 adenovirus plasmids for 24 h. Scale bar, 100 μm. ***p < 0.001, AS vs normal, ###p < 0.001, AS + sh-USP7 vs AS + sh-NC. NC, negative control; AS, atherosclerosis.
Figure 2
Figure 2
ELISA showed the secretion of IL-6, TNF-α, and IL-1β in the serum (up) and aortic tissues (down) of normal mice and AS (ApoE-deficient) mice, as well as AS mice infected with sh-NC or sh-USP7 adenovirus plasmids for 24 h.
Figure 3
Figure 3
Depletion of USP7 restrained oxidative stress in AS mice. (a) DHE staining showed the oxidative stress (ROS levels) in the aortic tissues of normal mice and AS (ApoE-deficient) mice, as well as AS mice infected with sh-NC or sh-USP7 adenovirus plasmids for 24 h. Scale bar, 200 μm. (b) Levels of MDA, SOD, and GSH-Px in the aortic tissues of normal mice and AS (ApoE-deficient) mice, as well as AS mice infected with sh-NC or sh-USP7 adenovirus plasmids for 24 h, were measured using corresponding kits. ***p < 0.001, AS vs normal, ##p < 0.01, ###p < 0.001, AS + sh-USP7 vs AS + sh-NC. NC, negative control; AS, atherosclerosis.
Figure 4
Figure 4
USP7 knockdown blocked the lipid accumulation of aortic tissues in AS mice. (a) TC and TG levels in the aortic tissues of normal mice and AS (ApoE-deficient) mice, as well as AS mice infected with sh-NC or sh-USP7 adenovirus plasmids for 24 h, were detected using corresponding kits. (b) Oil Red O staining showed the degree of lipid accumulation in the aortic tissues of normal mice and AS (ApoE-deficient) mice, as well as AS mice infected with sh-NC or sh-USP7 adenovirus plasmids for 24 h. Scale bar, 40 μm. ***p < 0.001, AS vs normal, ###p < 0.001, AS + sh-USP7 vs AS + sh-NC. NC, negative control; AS, atherosclerosis.
Figure 5
Figure 5
USP7 knockdown inhibited EZH2 expression in AS mice. (a) Immunoblot assays showed the expression of EZH2 in the aortic tissues of normal mice and AS (ApoE-deficient) mice, as well as AS mice infected with sh-NC or sh-USP7 adenovirus plasmids for 24 h. (b) Immunoblot assays showed the expression of EZH2 in the aortic tissues of AS mice infected with sh-NC or sh-USP7 and EZH2 adenovirus plasmids. (c) ELISA showed the secretion of IL-6, TNF-α, and IL-1β in the aortic tissues of AS mice infected with sh-NC or sh-USP7 and EZH2 adenovirus plasmids for 24 h. (d) Levels of MDA, SOD, and GSH-Px in the aortic tissues of AS mice infected with sh-NC or sh-USP7 and EZH2 adenovirus plasmids for 24 h were measured using corresponding kits. (e) TC and TG levels in the aortic tissues of AS mice infected with sh-NC or sh-USP7 and EZH2 adenovirus plasmids were detected using corresponding kits. **p < 0.01, ***p < 0.001, AS vs normal, ##p < 0.01, ###p < 0.001, AS + sh-USP7 vs AS + sh-NC. NC, negative control; AS, atherosclerosis.

Similar articles

Cited by

References

    1. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47(8 Suppl):C7–12. - PubMed
    1. Libby P, Bornfeldt KE, Tall AR. Atherosclerosis: successes, surprises, and future challenges. Circ Res. 2016;118(4):531–4. - PMC - PubMed
    1. Choi HY, Iatan I, Ruel I, Brown L, Hales L, Choi S, et al. Docetaxel as a model compound to promote HDL (high-density lipoprotein) biogenesis and reduce atherosclerosis. Arterioscler Thromb Vasc Biol. 2023;43(5):609–17. - PubMed
    1. Zeng J, Zhang J, Sun Y, Wang J, Ren C, Banerjee S, et al. Targeting EZH2 for cancer therapy: from current progress to novel strategies. Eur J Med Chem. 2022;238:114419. - PubMed
    1. Mónika R, Ferenc O, András S, Erika T, Örs F, István K, et al. EZH2 expression in head-and-neck squamous cell cancer in young patients. Int J Mol Sci. 2024;25. 10.3390/ijms25105250. - DOI - PMC - PubMed

LinkOut - more resources